:@0.085519:0.075583:0.090751:0.075583:0.090751:0.059604:0.085519:0.059604:0.005232
 :@0.621674:0.075583:0.626906:0.075583:0.626906:0.059604:0.621674:0.059604:0.005232
 :@0.884977:0.940183:0.890322:0.940183:0.890322:0.922163:0.884977:0.922163:0.005345
Oral Presenter Abstract :@0.736982:0.075583:0.918858:0.075583:0.918858:0.059604:0.736982:0.059604:0.011658:0.006331:0.008492:0.004000:0.005293:0.010369:0.006331:0.008929:0.008569:0.008929:0.009573:0.005251:0.008929:0.006382:0.005321:0.010407:0.009403:0.008511:0.005289:0.006275:0.008531:0.008531:0.005340:0.005232
OT-5 :@0.083238:0.078822:0.144017:0.078822:0.144017:0.060055:0.083238:0.060055:0.018387:0.014681:0.007982:0.013113:0.006617
Gene Expression Analysis of :@0.103763:0.158311:0.412041:0.158311:0.412041:0.136326:0.103763:0.136326:0.016067:0.013120:0.013355:0.013120:0.006521:0.013094:0.011685:0.013537:0.008686:0.013146:0.011842:0.011842:0.006651:0.013120:0.013355:0.006573:0.014372:0.013355:0.012729:0.006651:0.011685:0.011842:0.006703:0.011685:0.006521:0.013120:0.007381:0.006521
Giardia lamblia:@0.412391:0.158311:0.574159:0.158311:0.574159:0.136326:0.412391:0.136326:0.016067:0.006703:0.012650:0.008686:0.013537:0.006729:0.012546:0.006521:0.006703:0.012546:0.019589:0.013485:0.006651:0.006703:0.012650
 Small GTPase, Rho subfamily :@0.574354:0.158311:0.902517:0.158311:0.902517:0.136326:0.574354:0.136326:0.006556:0.014398:0.019641:0.012650:0.006703:0.006651:0.006521:0.016067:0.013042:0.014659:0.012729:0.011842:0.013068:0.008686:0.006521:0.015415:0.013433:0.013042:0.006521:0.011842:0.013355:0.013485:0.007434:0.012650:0.019667:0.006651:0.006729:0.011685:0.006521
protein treated with Dasatinib inhibitor :@0.292522:0.182399:0.713999:0.182399:0.713999:0.160414:0.292522:0.160414:0.013537:0.008686:0.013094:0.007668:0.013068:0.006756:0.013355:0.006573:0.007668:0.008686:0.013120:0.012650:0.007668:0.013068:0.013537:0.006521:0.017424:0.006651:0.007668:0.013407:0.006521:0.016119:0.012650:0.011842:0.012650:0.007721:0.006547:0.013355:0.006703:0.013485:0.006573:0.006651:0.013407:0.013355:0.006651:0.013485:0.006651:0.007721:0.013042:0.009023:0.006521
Haneen Imad Abdulsattar, Nurhana Jasni and Nurulhasanah Othman*:@0.173793:0.224794:0.826360:0.224794:0.826360:0.204731:0.173793:0.204731:0.014639:0.010664:0.011925:0.011211:0.011140:0.011925:0.006570:0.005736:0.018495:0.010545:0.011901:0.006570:0.013020:0.011901:0.011901:0.011925:0.005022:0.010545:0.010664:0.006546:0.006546:0.010664:0.007974:0.005951:0.006570:0.014567:0.011925:0.007950:0.011901:0.010664:0.011925:0.010664:0.006563:0.010545:0.010664:0.010687:0.011925:0.004925:0.006556:0.010545:0.011925:0.011880:0.006556:0.014662:0.011925:0.007950:0.011925:0.004856:0.011901:0.010735:0.010545:0.010664:0.011925:0.010664:0.011901:0.006450:0.014639:0.006546:0.011901:0.018447:0.010664:0.011925:0.009426
 :@0.826207:0.225132:0.832728:0.225132:0.832728:0.203147:0.826207:0.203147:0.006521
Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Penang :@0.153649:0.254771:0.851791:0.254771:0.851791:0.236750:0.153649:0.236750:0.004789:0.009621:0.008253:0.004661:0.004276:0.004725:0.009599:0.004661:0.008680:0.005388:0.004682:0.009578:0.005986:0.005388:0.010925:0.008766:0.008253:0.008680:0.008231:0.006072:0.008210:0.009557:0.005388:0.004276:0.009557:0.005388:0.015308:0.009493:0.004276:0.008702:0.008381:0.009599:0.004276:0.008231:0.006072:0.005430:0.015308:0.008637:0.009578:0.004276:0.008295:0.004276:0.009621:0.008766:0.005345:0.006008:0.004789:0.011866:0.009578:0.011802:0.010925:0.015308:0.015244:0.006008:0.004977:0.005416:0.011802:0.009621:0.004276:0.008231:0.008680:0.006072:0.008295:0.004276:0.004661:0.004276:0.005430:0.010540:0.008231:0.004276:0.009621:0.008253:0.005259:0.015308:0.008231:0.004276:0.008231:0.008274:0.008253:0.004276:0.008231:0.004825:0.005416:0.010626:0.008766:0.009535:0.008231:0.009621:0.009521:0.005345
*Corresponding Author: nurulhasanah@usm.my :@0.318035:0.284603:0.687310:0.284603:0.687310:0.266583:0.318035:0.266583:0.008188:0.011823:0.009493:0.006072:0.006157:0.008702:0.008253:0.009578:0.009578:0.009514:0.009578:0.004361:0.009557:0.009557:0.005345:0.010733:0.009599:0.004661:0.009535:0.009578:0.006072:0.004682:0.005578:0.009557:0.009599:0.006072:0.009599:0.004276:0.009514:0.008231:0.008253:0.008295:0.009557:0.008381:0.009557:0.017147:0.009514:0.008253:0.014367:0.004725:0.014367:0.008473:0.005345
Giardiasis, caused by the protozoan parasite :@0.171085:0.326487:0.556213:0.326487:0.556213:0.306424:0.171085:0.306424:0.013163:0.004665:0.009164:0.006665:0.010664:0.004761:0.009093:0.009236:0.004761:0.009188:0.005260:0.008378:0.009236:0.009164:0.010545:0.009236:0.009759:0.010664:0.008355:0.010664:0.009212:0.008331:0.005189:0.010640:0.009759:0.008307:0.010664:0.006760:0.010664:0.005189:0.010473:0.008069:0.010664:0.009069:0.010711:0.008355:0.010664:0.009164:0.006689:0.009164:0.009188:0.004761:0.005118:0.009759:0.005951
Giardia lamblia:@0.558818:0.326487:0.684544:0.326487:0.684544:0.306424:0.558818:0.306424:0.013163:0.004665:0.009164:0.006665:0.010806:0.004761:0.009069:0.008378:0.004761:0.009069:0.015995:0.010664:0.004761:0.004642:0.009164
, is commonly treated with :@0.684531:0.326487:0.920439:0.326487:0.920439:0.306424:0.684531:0.306424:0.005213:0.008450:0.004761:0.009188:0.008402:0.009236:0.010568:0.015995:0.015995:0.010664:0.010711:0.004642:0.009212:0.008450:0.005189:0.006641:0.009759:0.009045:0.005189:0.009640:0.010664:0.008402:0.013377:0.004761:0.005094:0.010711:0.005951
Metronidazole as the primary therapeutic option. However, the emergence of adverse effects and :@0.085519:0.349869:0.920114:0.349869:0.920114:0.329806:0.085519:0.329806:0.017043:0.009759:0.005189:0.006641:0.010664:0.010711:0.004761:0.010664:0.009164:0.008069:0.010664:0.004761:0.009640:0.007950:0.009164:0.009069:0.007950:0.005189:0.010640:0.009759:0.007902:0.010664:0.006760:0.004665:0.015995:0.009093:0.006760:0.009212:0.007950:0.005189:0.010640:0.009759:0.006760:0.009164:0.010664:0.009759:0.010687:0.005070:0.004761:0.009236:0.007926:0.010664:0.010664:0.005189:0.004761:0.010664:0.010711:0.005213:0.007807:0.013139:0.010664:0.013377:0.009759:0.009069:0.009759:0.006641:0.005213:0.008021:0.005189:0.010640:0.009759:0.007902:0.009759:0.015900:0.009759:0.006641:0.010640:0.009759:0.010711:0.009236:0.009688:0.007950:0.010664:0.005284:0.007950:0.009164:0.010664:0.009164:0.009640:0.006546:0.009236:0.009759:0.007902:0.009759:0.005070:0.005213:0.009759:0.009236:0.005189:0.009188:0.007998:0.009164:0.010711:0.010473:0.005951
resistance  to  Metronidazole  has  inspired  research  into  new  treatments.  This  study  focused  on :@0.085519:0.373151:0.919924:0.373151:0.919924:0.353088:0.085519:0.353088:0.006760:0.009640:0.009236:0.004761:0.009188:0.005189:0.009093:0.010711:0.009236:0.009759:0.005951:0.004094:0.005189:0.010664:0.005951:0.004118:0.016971:0.009759:0.005070:0.006760:0.010664:0.010711:0.004642:0.010664:0.009164:0.008069:0.010664:0.004761:0.009759:0.005951:0.004094:0.010711:0.009164:0.009188:0.005951:0.004165:0.004761:0.010640:0.009236:0.010664:0.004761:0.006665:0.009759:0.010664:0.005951:0.004094:0.006760:0.009640:0.009236:0.009759:0.009045:0.006760:0.009236:0.010711:0.005951:0.004094:0.004761:0.010640:0.005189:0.010664:0.005951:0.004118:0.010711:0.009664:0.013377:0.005951:0.004165:0.005189:0.006641:0.009759:0.009045:0.005189:0.015900:0.009759:0.010616:0.005189:0.009188:0.005260:0.005951:0.004142:0.010640:0.010711:0.004761:0.009188:0.005951:0.004046:0.009236:0.004999:0.010687:0.010664:0.009259:0.005951:0.003999:0.005213:0.010735:0.009117:0.010687:0.009236:0.009759:0.010664:0.005951:0.003951:0.010664:0.010568:0.005951
investigating the potential of RhoGTPase family proteins as targets for drug intervention in :@0.085519:0.396533:0.828274:0.396533:0.828274:0.376470:0.085519:0.376470:0.004761:0.010640:0.009164:0.009640:0.009236:0.005189:0.004642:0.010640:0.009164:0.005189:0.004665:0.010711:0.010640:0.004880:0.005189:0.010640:0.009759:0.004927:0.010664:0.010664:0.005189:0.009688:0.010711:0.005118:0.004761:0.009069:0.004761:0.004784:0.010664:0.005284:0.004856:0.012163:0.010711:0.010664:0.013068:0.010640:0.011830:0.009164:0.009259:0.009759:0.004704:0.005213:0.009164:0.015995:0.004761:0.004642:0.009212:0.004903:0.010664:0.006760:0.010664:0.005189:0.009616:0.004761:0.010640:0.009236:0.004856:0.009164:0.009188:0.004880:0.005189:0.009069:0.006760:0.010640:0.009688:0.005189:0.009188:0.004856:0.005141:0.010664:0.006593:0.004856:0.010664:0.006760:0.010687:0.010640:0.004856:0.004761:0.010640:0.005189:0.009640:0.006760:0.009069:0.009759:0.010616:0.005189:0.004642:0.010806:0.010711:0.004832:0.004761:0.010640:0.005951
G. lamblia:@0.827204:0.396533:0.909490:0.396533:0.909490:0.376470:0.827204:0.376470:0.013163:0.005213:0.004856:0.004761:0.009069:0.015995:0.010664:0.004761:0.004642:0.009164
. :@0.909493:0.396533:0.920574:0.396533:0.920574:0.376470:0.909493:0.376470:0.005131:0.005951
Based on its involvement in metabolic processes, as indicated by the UniProtKB database, and :@0.085519:0.419949:0.920043:0.419949:0.920043:0.399886:0.085519:0.399886:0.011830:0.009164:0.009188:0.009759:0.010664:0.009093:0.010664:0.010711:0.009236:0.004761:0.005070:0.009188:0.009164:0.004761:0.010640:0.008974:0.010664:0.004761:0.009093:0.009759:0.015900:0.009759:0.010616:0.005189:0.009188:0.004761:0.010640:0.009236:0.015995:0.009664:0.005260:0.009164:0.010664:0.010664:0.004761:0.004665:0.009236:0.009259:0.010664:0.006760:0.010521:0.009236:0.009759:0.009093:0.009236:0.009759:0.009045:0.005213:0.009307:0.008974:0.009236:0.009236:0.004761:0.010640:0.010664:0.004761:0.009236:0.009164:0.005094:0.009759:0.010473:0.009236:0.010664:0.009212:0.009188:0.005189:0.010640:0.009759:0.009164:0.013139:0.010711:0.004665:0.011830:0.006760:0.010664:0.005094:0.011806:0.011711:0.009093:0.010664:0.009164:0.005118:0.009164:0.010664:0.009164:0.009188:0.009759:0.005213:0.009259:0.009164:0.010711:0.010473:0.005951
previous findings showing up-regulation of Rho GTPase family protein in the virulent variant of :@0.085519:0.443332:0.897103:0.443332:0.897103:0.423269:0.085519:0.423269:0.010664:0.006760:0.009664:0.009164:0.004665:0.010664:0.010687:0.009259:0.007093:0.005213:0.004761:0.010711:0.010664:0.004761:0.010711:0.010473:0.009188:0.007046:0.009236:0.010711:0.010521:0.013377:0.004761:0.010711:0.010640:0.007093:0.010687:0.010734:0.007982:0.006760:0.009640:0.010545:0.010687:0.004761:0.009069:0.005189:0.004642:0.010664:0.010711:0.007117:0.010664:0.005284:0.007093:0.012163:0.010711:0.010664:0.007069:0.012972:0.010640:0.011830:0.009164:0.009259:0.009759:0.007046:0.005213:0.009164:0.015995:0.004761:0.004642:0.009212:0.007022:0.010664:0.006760:0.010521:0.005189:0.009640:0.004761:0.010640:0.007093:0.004761:0.010640:0.007093:0.005189:0.010640:0.009759:0.007046:0.009236:0.004761:0.006641:0.010687:0.004761:0.009759:0.010711:0.005189:0.007046:0.009164:0.009069:0.006760:0.004642:0.009164:0.010759:0.005189:0.007046:0.010664:0.005284:0.005951
E. :@0.898660:0.443332:0.920559:0.443332:0.920559:0.423269:0.898660:0.423269:0.010545:0.005403:0.005951
histolytica:@0.085519:0.466714:0.168233:0.466714:0.168233:0.446651:0.085519:0.446651:0.010711:0.004689:0.009236:0.005189:0.010664:0.004665:0.009212:0.005189:0.004761:0.009236:0.009164
, another protozoan parasite, it was hypothesized that by inhibiting RhoGTPase family :@0.168235:0.466714:0.920139:0.466714:0.920139:0.446651:0.168235:0.446651:0.005213:0.009307:0.009164:0.010711:0.010664:0.005094:0.010711:0.009664:0.006760:0.009188:0.010664:0.006760:0.010664:0.005189:0.010664:0.008069:0.010664:0.009164:0.010711:0.009212:0.010664:0.009164:0.006546:0.009164:0.009188:0.004761:0.005118:0.009759:0.005213:0.009236:0.004761:0.005070:0.009236:0.013377:0.009164:0.009188:0.009307:0.010711:0.009212:0.010568:0.010664:0.005189:0.010711:0.009640:0.009236:0.004761:0.008069:0.009759:0.010664:0.009188:0.005189:0.010640:0.009164:0.005094:0.009236:0.010664:0.009259:0.009236:0.004761:0.010640:0.010711:0.004689:0.010664:0.004761:0.005094:0.004761:0.010640:0.010640:0.009283:0.012163:0.010711:0.010664:0.013068:0.010640:0.011830:0.009164:0.009259:0.009759:0.009164:0.005213:0.009164:0.015995:0.004761:0.004642:0.009117:0.005951
proteins, the :@0.085519:0.489996:0.198677:0.489996:0.198677:0.469933:0.085519:0.469933:0.010664:0.006760:0.010664:0.005189:0.009616:0.004761:0.010640:0.009236:0.005213:0.008879:0.005189:0.010640:0.009759:0.005951
G. lamblia:@0.201587:0.489996:0.287705:0.489996:0.287705:0.469933:0.201587:0.469933:0.013163:0.005213:0.008688:0.004761:0.009069:0.015995:0.010664:0.004761:0.004642:0.009164
 metabolic process could be interrupted, leading to the parasite's death. :@0.287676:0.489996:0.920144:0.489996:0.920144:0.469933:0.287676:0.469933:0.008837:0.015995:0.009759:0.005189:0.009164:0.010664:0.010664:0.004761:0.004761:0.009236:0.008879:0.010664:0.006760:0.010664:0.009236:0.009759:0.009069:0.009236:0.008807:0.009117:0.010664:0.010687:0.004761:0.010521:0.008807:0.010664:0.009759:0.008783:0.004761:0.010640:0.005189:0.009640:0.006760:0.006641:0.010687:0.010664:0.005284:0.009759:0.010664:0.005213:0.008831:0.004761:0.009640:0.009164:0.010664:0.004689:0.010711:0.010640:0.008831:0.005189:0.010664:0.008783:0.005189:0.010640:0.009759:0.008736:0.010806:0.009164:0.006665:0.009164:0.009188:0.004761:0.005118:0.009759:0.004642:0.009236:0.008807:0.010664:0.009759:0.009093:0.005189:0.010640:0.005213:0.005951
Previous analyses utilised target sequence analysis in the DrugBank database, molecular docking, :@0.085519:0.513378:0.920114:0.513378:0.920114:0.493315:0.085519:0.493315:0.011830:0.006760:0.009640:0.009164:0.004665:0.010664:0.010687:0.009259:0.007236:0.009164:0.010711:0.009069:0.004761:0.009212:0.009236:0.009759:0.009188:0.007260:0.010687:0.005189:0.004642:0.004761:0.004642:0.009236:0.009759:0.010664:0.007212:0.005189:0.009069:0.006760:0.010640:0.009688:0.005189:0.007331:0.009236:0.009759:0.010664:0.010687:0.009664:0.010711:0.009236:0.009759:0.007188:0.009164:0.010711:0.009069:0.004761:0.009212:0.009236:0.004570:0.009236:0.007236:0.004761:0.010640:0.007236:0.005189:0.010640:0.009759:0.007188:0.013115:0.006760:0.010687:0.010640:0.011830:0.009164:0.010497:0.009164:0.007212:0.010664:0.009164:0.005118:0.009164:0.010664:0.009164:0.009188:0.009759:0.005213:0.007260:0.015995:0.010664:0.004761:0.009640:0.009236:0.010687:0.004761:0.009164:0.006641:0.007236:0.010664:0.010664:0.009283:0.009164:0.004665:0.010711:0.010640:0.005213:0.005951
molecular dynamic simulations, and minimal inhibitory concentration (MIC) test, demonstrating a :@0.085519:0.536760:0.920517:0.536760:0.920517:0.516698:0.085519:0.516698:0.015995:0.010664:0.004761:0.009640:0.009236:0.010687:0.004761:0.009164:0.006641:0.007950:0.010664:0.009259:0.010711:0.009164:0.015900:0.004761:0.009236:0.007926:0.009236:0.004761:0.015900:0.010687:0.004761:0.009069:0.005189:0.004642:0.010664:0.010711:0.009236:0.005141:0.007950:0.008974:0.010711:0.010664:0.007974:0.015995:0.004665:0.010711:0.004689:0.015995:0.009093:0.004761:0.007902:0.004761:0.010640:0.010711:0.004689:0.010664:0.004761:0.005094:0.010664:0.006760:0.009212:0.007974:0.009236:0.010664:0.010592:0.009236:0.009759:0.010711:0.005070:0.006760:0.009069:0.005189:0.004761:0.010664:0.010711:0.007998:0.006546:0.017043:0.005332:0.013163:0.006689:0.007926:0.005189:0.009640:0.009236:0.005189:0.005070:0.007950:0.010545:0.009759:0.015900:0.010664:0.011138:0.009236:0.005189:0.006641:0.009164:0.005094:0.004761:0.010640:0.010640:0.007998:0.009164:0.005951
strong  binding  affinity  between  the  putative  Rho  GTPase-activating  protein  and  Dasatinib.  This :@0.085519:0.560143:0.920437:0.560143:0.920437:0.540080:0.085519:0.540080:0.009236:0.005189:0.006641:0.010664:0.010711:0.010640:0.005951:0.004189:0.010664:0.004761:0.010711:0.010664:0.004689:0.010545:0.010640:0.005951:0.004189:0.009164:0.005213:0.005260:0.004761:0.010640:0.004761:0.005070:0.009212:0.005951:0.004189:0.010664:0.009759:0.005094:0.013377:0.009759:0.009640:0.010711:0.005951:0.004118:0.005189:0.010640:0.009759:0.005951:0.004070:0.010664:0.010687:0.005189:0.009164:0.005070:0.004761:0.009069:0.009759:0.005951:0.004070:0.012163:0.010711:0.010735:0.005951:0.004142:0.013163:0.010640:0.011830:0.009164:0.009188:0.010098:0.007982:0.009164:0.009236:0.005189:0.004642:0.009164:0.009069:0.005189:0.004761:0.010711:0.010640:0.005951:0.004213:0.010664:0.006760:0.010664:0.005189:0.009616:0.004761:0.010640:0.005951:0.004142:0.009164:0.010711:0.010664:0.005951:0.004118:0.013115:0.009164:0.009188:0.009164:0.005189:0.004642:0.010711:0.004689:0.010664:0.005284:0.005951:0.004142:0.010640:0.010711:0.004761:0.008950:0.005951
binding suggested that Dasatinib could be effective in killing this parasite at minimal inhibitory :@0.085519:0.583525:0.919900:0.583525:0.919900:0.563462:0.085519:0.563462:0.010664:0.004761:0.010711:0.010664:0.004689:0.010711:0.010640:0.009402:0.009236:0.010545:0.010640:0.010711:0.009545:0.009236:0.005189:0.009640:0.010664:0.009402:0.005189:0.010640:0.009164:0.005094:0.009378:0.013115:0.009164:0.009188:0.009164:0.005189:0.004642:0.010711:0.004761:0.010735:0.009378:0.009236:0.010664:0.010687:0.004761:0.010664:0.009259:0.010664:0.009759:0.009331:0.009759:0.005213:0.005213:0.009759:0.009117:0.005189:0.004642:0.009164:0.009640:0.009378:0.004761:0.010640:0.009378:0.009236:0.004761:0.004642:0.004832:0.004761:0.010640:0.010640:0.009426:0.005189:0.010640:0.004832:0.009236:0.009378:0.010664:0.009164:0.006689:0.009164:0.009188:0.004761:0.005118:0.009759:0.009307:0.009164:0.005094:0.009378:0.015995:0.004761:0.010711:0.004761:0.015995:0.009069:0.004761:0.009331:0.004761:0.010640:0.010711:0.004689:0.010664:0.004856:0.005189:0.010664:0.006665:0.009117:0.005951
concentrations. Therefore, this study was designed to explore the effects of inhibiting the putative :@0.085519:0.606908:0.920262:0.606908:0.920262:0.586845:0.085519:0.586845:0.009236:0.010664:0.010711:0.009236:0.009759:0.010711:0.005118:0.006760:0.009069:0.005189:0.004642:0.010664:0.010711:0.009236:0.005213:0.007307:0.010545:0.010711:0.009664:0.006760:0.009640:0.005213:0.010735:0.006760:0.009640:0.005213:0.007307:0.005189:0.010640:0.004761:0.009188:0.007260:0.009236:0.005189:0.010687:0.010664:0.009212:0.007260:0.013377:0.009164:0.009188:0.007165:0.010664:0.009759:0.009188:0.004761:0.010640:0.010711:0.009759:0.010497:0.007526:0.005189:0.010664:0.007212:0.009759:0.009474:0.010664:0.004761:0.010664:0.006760:0.009640:0.007236:0.005189:0.010640:0.009759:0.007188:0.009807:0.005213:0.005308:0.009759:0.009236:0.005094:0.009236:0.007093:0.010664:0.005284:0.007236:0.004761:0.010640:0.010711:0.004689:0.010664:0.004761:0.005094:0.004761:0.010640:0.010640:0.007284:0.005189:0.010640:0.009759:0.007188:0.010664:0.010687:0.005189:0.009164:0.005070:0.004761:0.009164:0.009854:0.005951
Rho GTPase-activating protein with Dasatinib on the small GTPase, Rho subfamily protein, through :@0.085519:0.630189:0.920200:0.630189:0.920200:0.610126:0.085519:0.610126:0.012163:0.010711:0.010664:0.006355:0.013163:0.010640:0.011830:0.008974:0.009236:0.009790:0.007982:0.009164:0.009236:0.005189:0.004642:0.009164:0.009069:0.005189:0.004642:0.010711:0.010640:0.006427:0.010664:0.006760:0.010664:0.005189:0.009616:0.004761:0.010640:0.006379:0.013377:0.004761:0.005094:0.010711:0.006379:0.013115:0.009164:0.009188:0.009164:0.005189:0.004642:0.010711:0.004689:0.010664:0.006284:0.010664:0.010711:0.006403:0.005189:0.010497:0.009759:0.006331:0.009236:0.015995:0.009093:0.004761:0.004642:0.006379:0.013163:0.010640:0.011830:0.008974:0.009236:0.009759:0.005213:0.006236:0.012163:0.010711:0.010664:0.006212:0.009236:0.010687:0.010545:0.005213:0.009164:0.015995:0.004761:0.004642:0.009212:0.006450:0.010664:0.006593:0.010664:0.005189:0.009664:0.004761:0.010640:0.005213:0.006450:0.005189:0.010640:0.006760:0.010664:0.010687:0.010640:0.010568:0.005951
gene expression analysis.  :@0.085519:0.653572:0.317572:0.653572:0.317572:0.633509:0.085519:0.633509:0.010640:0.009759:0.010711:0.009664:0.008664:0.009759:0.009474:0.010664:0.006760:0.009664:0.009188:0.009188:0.004761:0.010664:0.010521:0.008664:0.009164:0.010711:0.009069:0.004761:0.009212:0.009236:0.004761:0.009069:0.005391:0.005986:0.005951
G. lamblia:@0.320315:0.653572:0.406148:0.653572:0.406148:0.633509:0.320315:0.633509:0.012972:0.005213:0.008736:0.004761:0.008926:0.015995:0.010664:0.004761:0.004642:0.009164
 trophozoites were cultured and treated with MIC 12.5 µM :@0.406119:0.653572:0.920217:0.653572:0.920217:0.633509:0.406119:0.633509:0.008694:0.005189:0.006641:0.010664:0.010664:0.010711:0.010664:0.008164:0.010664:0.004761:0.005094:0.009759:0.009188:0.008688:0.013377:0.009759:0.006641:0.009759:0.008593:0.009236:0.010687:0.004761:0.005094:0.010687:0.006760:0.009640:0.010664:0.008688:0.009164:0.010711:0.010664:0.008640:0.005189:0.006641:0.009759:0.009045:0.005189:0.009640:0.010664:0.008688:0.013377:0.004761:0.005189:0.010711:0.008688:0.017043:0.005332:0.013163:0.008616:0.010545:0.010664:0.005213:0.010664:0.008640:0.010687:0.016971:0.005951
Dasatinib at three different time points, before parasite death, which occurred within 48 hours. The :@0.085519:0.676988:0.920019:0.676988:0.920019:0.656925:0.085519:0.656925:0.013115:0.009164:0.009188:0.009164:0.005189:0.004642:0.010711:0.004689:0.010664:0.006570:0.009164:0.005094:0.006522:0.005189:0.010640:0.006760:0.009759:0.009759:0.006474:0.010664:0.004761:0.005213:0.005284:0.009759:0.006641:0.009759:0.010616:0.005189:0.006474:0.005189:0.004642:0.015995:0.009664:0.006522:0.010664:0.010664:0.004761:0.010711:0.005094:0.009236:0.005213:0.006593:0.010664:0.009569:0.005213:0.010735:0.006760:0.009640:0.006522:0.010664:0.009164:0.006546:0.009164:0.009188:0.004761:0.005118:0.009759:0.006474:0.010664:0.009759:0.009093:0.005189:0.010640:0.005213:0.006593:0.013377:0.010711:0.004761:0.009236:0.010711:0.006474:0.010664:0.009236:0.009307:0.010687:0.006760:0.006641:0.009759:0.010664:0.006498:0.013377:0.004761:0.005094:0.010711:0.004546:0.010711:0.006522:0.010664:0.010664:0.006593:0.010545:0.010664:0.010687:0.006760:0.009093:0.005213:0.006593:0.010545:0.010711:0.009759:0.005951
RNA  was  extracted  using  the  TRIzol  reagent,  quantified,  purified,  and  reverse-transcribed  into :@0.085519:0.700370:0.920534:0.700370:0.920534:0.680307:0.085519:0.680307:0.012163:0.013068:0.011901:0.005951:0.004784:0.013377:0.008998:0.009236:0.005951:0.004713:0.009545:0.009521:0.005189:0.006641:0.009164:0.009236:0.005189:0.009616:0.010664:0.005951:0.004737:0.010687:0.009236:0.004761:0.010497:0.010640:0.005951:0.004761:0.005189:0.010640:0.009759:0.005951:0.004642:0.010545:0.012163:0.005237:0.008069:0.010711:0.004761:0.005951:0.004665:0.006760:0.009640:0.009164:0.010640:0.009759:0.010640:0.005189:0.005213:0.005951:0.004713:0.010545:0.010687:0.009164:0.010711:0.005070:0.004761:0.005213:0.004761:0.009640:0.010664:0.005284:0.005951:0.004713:0.010664:0.010687:0.006760:0.004665:0.005213:0.004761:0.009545:0.010664:0.005284:0.005951:0.004713:0.009164:0.010711:0.010473:0.005951:0.004713:0.006760:0.009640:0.009164:0.009640:0.006760:0.009188:0.010219:0.007982:0.005189:0.006641:0.009164:0.010711:0.009188:0.009236:0.006760:0.004689:0.010664:0.009759:0.010664:0.005951:0.004689:0.004761:0.010640:0.005189:0.010664:0.005951
complementary DNA (cDNA). Quantitative PCR (qPCR) was performed using specifically designed :@0.085519:0.723752:0.920138:0.723752:0.920138:0.703689:0.085519:0.703689:0.009265:0.010693:0.015961:0.010664:0.004761:0.009664:0.015995:0.009664:0.010711:0.005118:0.009164:0.006665:0.009212:0.007307:0.013115:0.013139:0.011901:0.007284:0.006546:0.009236:0.013115:0.012996:0.011901:0.006736:0.005213:0.007307:0.013139:0.010521:0.009164:0.010711:0.005070:0.004761:0.005070:0.009236:0.005189:0.004642:0.009236:0.009759:0.007188:0.011830:0.013163:0.012068:0.007236:0.006689:0.010664:0.011830:0.013163:0.012163:0.006689:0.007188:0.013377:0.009164:0.009188:0.007307:0.010664:0.009759:0.006665:0.005141:0.010664:0.006593:0.015995:0.009664:0.010664:0.007260:0.010687:0.009236:0.004761:0.010640:0.010640:0.007165:0.009236:0.010664:0.009759:0.009236:0.004546:0.005141:0.004761:0.009236:0.009164:0.004642:0.004761:0.009212:0.007236:0.010664:0.009759:0.009188:0.004761:0.010640:0.010711:0.009759:0.010664:0.005951
primers targeting the small GTPase, Rho subfamily protein, with Aldolase serving as the reference :@0.085519:0.747034:0.920019:0.747034:0.920019:0.726971:0.085519:0.726971:0.010664:0.006760:0.004665:0.015995:0.009664:0.006760:0.009188:0.006974:0.005189:0.009069:0.006760:0.010640:0.009688:0.005260:0.004761:0.010640:0.010640:0.007022:0.005189:0.010640:0.009759:0.006903:0.009236:0.015995:0.009093:0.004761:0.004642:0.006950:0.013163:0.010640:0.011830:0.009164:0.009188:0.009759:0.005213:0.006998:0.012163:0.010711:0.010664:0.006927:0.009236:0.010545:0.010664:0.005284:0.009164:0.015924:0.004761:0.004642:0.009117:0.006950:0.010664:0.006760:0.010664:0.005189:0.009616:0.004761:0.010640:0.005213:0.007022:0.013377:0.004761:0.005094:0.010711:0.006950:0.011901:0.004761:0.010664:0.010664:0.004761:0.009164:0.009188:0.009759:0.006927:0.009236:0.009759:0.006641:0.009164:0.004665:0.010711:0.010640:0.006998:0.009164:0.009188:0.006855:0.005189:0.010640:0.009759:0.006903:0.006760:0.009640:0.005213:0.009759:0.006760:0.009616:0.010711:0.009355:0.009807:0.005951
gene. The qPCR parameters were optimized, resulting in high PCR efficiency (reaction efficiency = :@0.085519:0.770416:0.920453:0.770416:0.920453:0.750353:0.085519:0.750353:0.010640:0.009759:0.010711:0.009664:0.005213:0.006736:0.010640:0.010711:0.009759:0.006498:0.010664:0.011830:0.013163:0.012092:0.006522:0.010664:0.009164:0.006689:0.009164:0.015924:0.009759:0.005070:0.009807:0.006760:0.009188:0.006689:0.013377:0.009759:0.006641:0.009759:0.006617:0.010664:0.010664:0.005189:0.004761:0.015900:0.004761:0.008069:0.009759:0.010664:0.005213:0.006689:0.006760:0.009640:0.009236:0.010687:0.004761:0.005070:0.004761:0.010640:0.010640:0.006736:0.004761:0.010640:0.006665:0.010711:0.004689:0.010640:0.010711:0.006570:0.011830:0.013163:0.012068:0.006522:0.009759:0.005213:0.005213:0.004761:0.009621:0.004761:0.009640:0.010711:0.009236:0.009212:0.006593:0.006689:0.006760:0.009640:0.009164:0.009236:0.005189:0.004761:0.010664:0.010711:0.006689:0.009759:0.005070:0.005213:0.004761:0.009236:0.004761:0.009664:0.010711:0.009236:0.009212:0.006736:0.010545:0.005951
1.18 and R² = 0.97502). Microscopic analysis revealed distinct morphological changes in the treated :@0.085519:0.793799:0.920305:0.793799:0.920305:0.773736:0.085519:0.773736:0.010664:0.005284:0.010545:0.010664:0.005308:0.009164:0.010711:0.010664:0.005237:0.012163:0.006355:0.005141:0.010664:0.005308:0.010545:0.005213:0.010664:0.010664:0.010664:0.010545:0.010664:0.006689:0.005284:0.005141:0.017043:0.004761:0.009236:0.006760:0.010521:0.009236:0.009117:0.010545:0.010664:0.004761:0.009236:0.005260:0.009164:0.010711:0.009069:0.004761:0.009212:0.009236:0.004761:0.009069:0.005284:0.006760:0.009640:0.009164:0.009640:0.009236:0.004761:0.009640:0.010664:0.005308:0.010664:0.004761:0.009188:0.005189:0.004761:0.010616:0.009236:0.005189:0.005237:0.015995:0.010664:0.006760:0.010664:0.010711:0.010664:0.004665:0.010664:0.010687:0.004761:0.009236:0.009164:0.004642:0.005284:0.009236:0.010711:0.009164:0.010711:0.010640:0.009545:0.009236:0.005284:0.004761:0.010640:0.005284:0.005189:0.010640:0.009759:0.005213:0.005189:0.006641:0.009759:0.009045:0.005189:0.009640:0.010806:0.005951
G. lamblia:@0.085519:0.817181:0.171780:0.817181:0.171780:0.797118:0.085519:0.797118:0.013163:0.005213:0.008831:0.004761:0.009069:0.015995:0.010664:0.004761:0.004642:0.009164
 cells, including shrinkage, loss of motility, and compromised cellular integrity, which :@0.171798:0.817181:0.920114:0.817181:0.920114:0.797118:0.171798:0.797118:0.008837:0.009236:0.009759:0.004665:0.004761:0.009188:0.005260:0.008807:0.004761:0.010640:0.009236:0.004761:0.010687:0.010664:0.004761:0.010640:0.010640:0.008855:0.009188:0.010616:0.006760:0.004642:0.010711:0.009164:0.009069:0.010640:0.009759:0.005213:0.008855:0.004761:0.010664:0.009093:0.009236:0.008664:0.010664:0.005284:0.008807:0.015829:0.010664:0.005189:0.004665:0.004761:0.004642:0.005189:0.009212:0.005213:0.008879:0.009164:0.010711:0.010664:0.008783:0.009236:0.010664:0.015995:0.010664:0.006760:0.010545:0.015995:0.004665:0.009236:0.009759:0.010664:0.008783:0.009236:0.009759:0.004665:0.004761:0.010687:0.004642:0.009164:0.006665:0.008807:0.004761:0.010711:0.005189:0.009759:0.010640:0.006689:0.004761:0.005070:0.009212:0.005308:0.008807:0.013377:0.010711:0.004761:0.009236:0.010521:0.005951
further supported the gene expression findings. Treatment with Dasatinib led to significant alterations :@0.085519:0.840563:0.920376:0.840563:0.920376:0.820501:0.085519:0.820501:0.005213:0.010687:0.006760:0.005189:0.010640:0.009759:0.006641:0.004856:0.009236:0.010687:0.010664:0.010568:0.010664:0.006760:0.005094:0.009759:0.010664:0.004808:0.005189:0.010640:0.009759:0.004784:0.010640:0.009759:0.010711:0.009664:0.004856:0.009759:0.009474:0.010664:0.006760:0.009664:0.009188:0.009045:0.004761:0.010664:0.010711:0.004784:0.005213:0.004761:0.010711:0.010664:0.004761:0.010711:0.010473:0.009188:0.005213:0.004689:0.010640:0.006760:0.009688:0.009164:0.005094:0.015995:0.009664:0.010711:0.005118:0.004856:0.013377:0.004761:0.005094:0.010711:0.004832:0.013115:0.009164:0.009188:0.009164:0.005189:0.004761:0.010711:0.004761:0.010664:0.004808:0.004761:0.009640:0.010664:0.004880:0.005189:0.010664:0.004665:0.009236:0.004761:0.010640:0.010711:0.004665:0.005213:0.004761:0.009117:0.009164:0.010711:0.005070:0.004856:0.009164:0.004665:0.005189:0.009759:0.006760:0.009069:0.005189:0.004642:0.010664:0.010711:0.009236:0.005951
in small GTPase, Rho subfamily protein gene expression. After 30 hours of treatment, the gene was :@0.085519:0.863946:0.920489:0.863946:0.920489:0.843883:0.085519:0.843883:0.004761:0.010640:0.005951:0.009283:0.015995:0.009093:0.004761:0.004642:0.005951:0.013163:0.010640:0.011830:0.009021:0.009236:0.009759:0.005070:0.005855:0.012163:0.010711:0.010664:0.005808:0.009236:0.010687:0.010545:0.005213:0.009164:0.015995:0.004761:0.004642:0.009212:0.006022:0.010664:0.006593:0.010664:0.005189:0.009664:0.004761:0.010640:0.005951:0.010711:0.009759:0.010616:0.009759:0.005951:0.009664:0.009521:0.010664:0.006760:0.009521:0.009236:0.009236:0.004761:0.010664:0.010521:0.005141:0.005951:0.011901:0.005213:0.005189:0.009664:0.006760:0.005951:0.010872:0.010545:0.005951:0.010592:0.010664:0.010687:0.006760:0.009093:0.005951:0.010664:0.005213:0.005951:0.005189:0.006665:0.009759:0.009045:0.005189:0.015900:0.009759:0.010616:0.005260:0.005213:0.006022:0.005189:0.010640:0.009759:0.005784:0.010640:0.009759:0.010711:0.009664:0.005951:0.013377:0.009045:0.009236:0.005951
upregulated with a fold change (Fc) of 3.22. However, at 36 hours, downregulation was observed :@0.085519:0.887227:0.919995:0.887227:0.919995:0.867165:0.085519:0.867165:0.010687:0.010664:0.006760:0.009664:0.010640:0.010687:0.004761:0.009164:0.005094:0.009759:0.010664:0.007212:0.013377:0.004761:0.005094:0.010806:0.007236:0.009164:0.007212:0.005213:0.010735:0.004761:0.010664:0.007212:0.009236:0.010711:0.009164:0.010711:0.010640:0.009688:0.007236:0.006546:0.010664:0.009236:0.006689:0.007307:0.010545:0.005213:0.007307:0.010545:0.005213:0.010735:0.010545:0.005213:0.007307:0.013139:0.010521:0.013258:0.009759:0.009045:0.009759:0.006641:0.005213:0.007307:0.009164:0.005094:0.007236:0.010664:0.010664:0.007307:0.010711:0.010664:0.010687:0.006760:0.009069:0.005213:0.007307:0.010664:0.010568:0.013377:0.010711:0.006760:0.009640:0.010640:0.010687:0.004761:0.009164:0.005094:0.004761:0.010664:0.010711:0.007188:0.013377:0.009164:0.009188:0.007307:0.010664:0.010568:0.009236:0.009759:0.006641:0.009164:0.009640:0.010806:0.005951
with Fc = 5.12, and by 42 hours, the gene expression had further reduced with an Fc = 3.16, :@0.085519:0.910610:0.919852:0.910610:0.919852:0.890547:0.085519:0.890547:0.013377:0.004761:0.005094:0.010711:0.008926:0.010664:0.009236:0.009021:0.010545:0.008950:0.010664:0.005213:0.010664:0.010521:0.005213:0.008879:0.009164:0.010711:0.010664:0.008926:0.010664:0.009259:0.008807:0.010664:0.010664:0.008855:0.010711:0.010664:0.010687:0.006570:0.009236:0.005213:0.009021:0.005189:0.010640:0.009759:0.008736:0.010640:0.009759:0.010711:0.009664:0.008950:0.009759:0.009474:0.010664:0.006593:0.009759:0.009188:0.009259:0.004761:0.010664:0.010711:0.008902:0.010711:0.008950:0.010664:0.008974:0.005213:0.010687:0.006760:0.005189:0.010497:0.009759:0.006641:0.008950:0.006760:0.009640:0.010664:0.010687:0.009236:0.009759:0.010664:0.008974:0.013377:0.004761:0.005094:0.010711:0.008926:0.009164:0.010711:0.008902:0.010664:0.009236:0.009021:0.010545:0.008950:0.010545:0.005213:0.010735:0.010545:0.005213:0.005951